Skip to main content
TRLV
NYSE Life Sciences

Trulieve Posts $230M Q3 Revenue, 64% Margin, $89M Adjusted EBITDA

Tom Rudovsky · Reported by PR Newswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$11.94
Mkt Cap
$2.234B
52W Low
$4.616
52W High
$13.28
52W Position info
159% above low
Off High info
10% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

TRLV has more than doubled off its 52-week low of $4.616.

Summary

Trulieve reported Q3 2026 revenue of $230 million with a 64% gross margin and $148 million in gross profit, producing $89 million of adjusted EBITDA (39% of revenue), $1 million of net income to common shareholders and adjusted EPS of 9 cents. Revenue fell 20% year over year, but that comparison is distorted: prior periods consolidated Harvest's mixed medical and adult-use operations, which were deconsolidated on June 3, 2026, and Q3 now reflects only the medical platform. Cash generation held up, with $74 million from operations and $45 million of free cash flow in the quarter, lifting cash to $327 million. The company also said it received final DEA registrations for state-licensed medical marijuana under the Schedule III rescheduling framework, which removes 280E tax exposure and underpins the NYSE uplisting. Management flagged Georgia, where traffic rose seven-fold after the July 1 program expansion, and Texas as the growth drivers. The 8:30 A.M. ET call will be the first chance to press management on the post-Harvest cost base and the pace of the Georgia and Texas ramp.

At the time of this announcement, TRLV was trading at $11.94 on NYSE in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $4.62 to $13.28. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

TRLV - Latest Insights

TRLV
Nov 05, 2026, 6:20 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.94
Real-time Price: $8.72 info
Change: -$3.22 (-27%) info
Market Cap: $1.674B info
TRLV
Aug 07, 2026, 6:22 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.51
Real-time Price: $8.72 info
Change: +$0.2063 (+2%) info
Market Cap: $1.674B info
TRLV
Aug 07, 2026, 6:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.51
Real-time Price: $8.72 info
Change: +$0.2063 (+2%) info
Market Cap: $1.674B info
TRLV
Jun 25, 2026, 5:13 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $8.48
Real-time Price: $8.72 info
Change: +$0.240 (+3%) info
Market Cap: $1.674B info
TRLV
Jun 17, 2026, 9:45 AM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $9.73
Real-time Price: $8.72 info
Change: -$1.00 (-10%) info
Market Cap: $1.674B info